C.129P2-Fcgr3tm1Jsv/Cnrm
Status | Available to order |
EMMA ID | EM:01745 |
Citation information | RRID:IMSR_EM:01745 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | C.129P2-Fcgr3tm1Jsv/Cnrm |
Alternative name | CD16 (Balb/C) 193 |
Strain type | Targeted Mutant Strains : Knock-out |
Allele/Transgene symbol | Fcgr3tm1Jsv |
Gene/Transgene symbol | Fcgr3 |
Information from provider
Provider | Verbeek J.S. Verbeek J.S. |
Provider affiliation | Leiden University Medical Center |
Genetic information | Deletion of exon 3 (ligand binding EC2 domain) and 5'-part of exon 4 (transmembrane domain), replaced by a PGK-hygromycin resistance cassette. |
Phenotypic information | Impaired IgG1 and IgG2b antibody effector pathways. |
References |
|
Information from EMMA
Archiving centre | CNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy |
Disease and phenotype information
IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
- abnormal leukocyte cell number / MGI
- increased neutrophil cell number / MGI
- impaired macrophage phagocytosis / MGI
- abnormal dendritic cell antigen presentation / MGI
- abnormal neutrophil physiology / MGI
- abnormal type I hypersensitivity reaction / MGI
- decreased susceptibility to induced arthritis / MGI
- decreased susceptibility to experimental autoimmune encephalomyelitis / MGI
- decreased susceptibility to autoimmune hemolytic anemia / MGI
- impaired natural killer cell mediated cytotoxicity / MGI
- decreased susceptibility to type I hypersensitivity reaction / MGI
- decreased susceptibility to type II hypersensitivity reaction / MGI
- impaired neutrophil recruitment / MGI
- decreased mast cell degranulation / MGI
Literature references
- Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice.;Hazenbos W L, Gessner J E, Hofhuis F M, Kuipers H, Meyer D, Heijnen I A, Schmidt R E, Sandor M, Capel P J, Daëron M, van de Winkel J G, Verbeek J S, ;1996;Immunity;5;181-8; 8769481
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).